ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 792,64
1,44%
DAX
18 518,03
-0,44%
Brent Oil
83,45
-1,06%
Bitcoin
64 502,58
-0,56%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
24/02/201420h41Business WireTeva Files 2013 Annual Report on Form 20-FNYSE:TEVATeva Pharmaceutical Industries Ltd
24/02/201417h47Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
24/02/201416h30Business WireTeva to Present at the Citi 2014 Global Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
21/02/201415h15Business WireTeva Completes Tender Offer for NuPathe Inc. SharesNYSE:TEVATeva Pharmaceutical Industries Ltd
21/02/201413h50Business WireTeva Receives CHMP Positive Opinion for DuoResp® Spiromax® for the Treatment of Patients Diagnosed with Asthma & COPD in Eu...NYSE:TEVATeva Pharmaceutical Industries Ltd
13/02/201414h30Business WireTeva Announces Full FDA Approval of SYNRIBO® (Omacetaxine Mepesuccinate) for InjectionNYSE:TEVATeva Pharmaceutical Industries Ltd
13/02/201412h07Edgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:TEVATeva Pharmaceutical Industries Ltd
11/02/201412h01PR Newswire (Canada)OncoGenex Announces Target Number of Events Reached in Phase 3 SYNERGY Trial of Custirsen in Metastatic Castrate-Resistant Pr...NYSE:TEVATeva Pharmaceutical Industries Ltd
10/02/201414h03Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NYSE:TEVATeva Pharmaceutical Industries Ltd
07/02/201419h20Business WireDEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of Teva Pharmaceutical Industries Limited of Upcoming DeadlineNYSE:TEVATeva Pharmaceutical Industries Ltd
06/02/201418h25Dow Jones NewsU.S. Hot Stocks: Hot Stocks to WatchNYSE:TEVATeva Pharmaceutical Industries Ltd
06/02/201413h00Business WireTeva Reports Fourth Quarter and Full Year 2013 ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
29/01/201400h30Business WireTeva Announces U.S. FDA Approval of Three-Times-a-Week COPAXONE® (glatiramer acetate injection) 40mg/mLNYSE:TEVATeva Pharmaceutical Industries Ltd
27/01/201419h31PR Newswire (US)Rigrodsky & Long, P.A. Files Securities Fraud Class Action Lawsuit Against Teva Pharmaceutical Industries LimitedNYSE:TEVATeva Pharmaceutical Industries Ltd
24/01/201415h01Dow Jones NewsTeva, Active Biotech Get Negative CHMP Opinion on MS TreatmentNYSE:TEVATeva Pharmaceutical Industries Ltd
24/01/201414h10Business WireTeva & Active Biotech Remain Committed to the Development of NERVENTRA® (laquinimod) for Multiple Sclerosis Following the Ne...NYSE:TEVATeva Pharmaceutical Industries Ltd
21/01/201413h00MarketwiredNuPathe Terminates Agreement With Endo and Enters Into Agreement to Be Acquired by TevaNYSE:TEVATeva Pharmaceutical Industries Ltd
21/01/201413h00Business WireTeva Expands CNS Specialty Business with Acquisition of NuPatheNYSE:TEVATeva Pharmaceutical Industries Ltd
15/01/201423h41Dow Jones NewsADR Shares End Higher; Teva, Petrobras Shares ActiveNYSE:TEVATeva Pharmaceutical Industries Ltd
15/01/201415h00PR Newswire (US)BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of DirectorsNYSE:TEVATeva Pharmaceutical Industries Ltd
13/01/201414h00Business WireData Demonstrates Key Genes Respond Differently to COPAXONE® (glatiramer acetate injection) Versus a Purported Generic Glati...NYSE:TEVATeva Pharmaceutical Industries Ltd
09/01/201421h03Business WireTeva to Present at the 32nd Annual J.P. Morgan Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
09/01/201418h13Business WireEQUITY ALERT: Rosen Law Firm Announces Class Action Lawsuit Against Teva Pharmaceutical Industries Limited --- TEVANYSE:TEVATeva Pharmaceutical Industries Ltd
09/01/201408h00Business WireTeva Names Erez Vigodman as President and CEONYSE:TEVATeva Pharmaceutical Industries Ltd
07/01/201418h25Business WireInvestor Alert: Upcoming Deadlines in Shareholder Litigation Involving Teva Pharmaceuticals and Tri-Tech Holdings, Inc.NYSE:TEVATeva Pharmaceutical Industries Ltd
03/01/201414h30Business WireTeva Announces Launch of Authorized Generic of Detrol®NYSE:TEVATeva Pharmaceutical Industries Ltd
19/12/201320h03Business WireTeva to Report Fourth Quarter 2013 Financial Results on February 6, 2014NYSE:TEVATeva Pharmaceutical Industries Ltd
17/12/201322h35Business WireTeva Settles Viagra® Patent Litigation with PfizerNYSE:TEVATeva Pharmaceutical Industries Ltd
10/12/201315h33Dow Jones NewsU.S. Hot Stocks Futures: Hot Stocks to WatchNYSE:TEVATeva Pharmaceutical Industries Ltd
10/12/201315h13Business WireProfessor Moshe Many to Leave Post as Vice Chairman Effective January 1, 2014, Will Remain a Member of the BoardNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

EU
VIV
Vivendi
EU
PX1
CAC 40
EU
LR
Legrand
EU
EN
Bouygues
EU
AF
Air FranceKLM
NYSE
JPM
JP Morgan Chase
EU
ORA
Orange
COIN
ETHUSD
Ethereum
EU
CAP
Capgemini
EU
RI
Pernod Ricard
EU
BNP
BNP Paribas
EU
CS
Axa
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés